Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Compass Therapeutics, Inc. | StockGist | StockGist

Companies
CMPX
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings CMPXSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Compass Therapeutics, Inc.

Filed Feb 13, 2026

Accepted Feb 12, 2026, 7:00 PM ET

CIK 0001738021

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

2,447,820

Reporting Person

Compass Therapeutics, Inc.

Person Type

PN

CUSIP: 20454B104

Amendment History

2 filings

SCHEDULE 13G
Original
Jan 21, 20260002012383-26-000660
SCHEDULE 13G/A
Amendment 1
Latest
Viewing
Feb 13, 20260001193125-26-051513

Key Facts

Shares Owned

2,447,820

Recent Filings

Compass Therapeutics, Inc.1 months ago

Compass Therapeutics, Inc.1 months ago

Compass Therapeutics, Inc.2 months ago

Compass Therapeutics, Inc.2 months ago

Compass Therapeutics, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice